Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis

被引:0
作者
Olejar, Tomas [1 ,2 ,3 ,4 ]
Jankovska, Nikol [1 ,2 ,3 ,4 ]
Matej, Radoslav [1 ,2 ,3 ,4 ,5 ,6 ]
机构
[1] Charles Univ Prague, Thomayer Univ Hosp, Fac Med 3, Dept Pathol & Mol Med, Prague 14000, Czech Republic
[2] Thomayer Fac Hosp, Prague 14059, Czech Republic
[3] Charles Univ Prague, Fac Med 3, Dept Pathol, Prague 10034, Czech Republic
[4] Univ Hosp Kralovske Vinohrady, Prague 10034, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Pathol, Prague 12800, Czech Republic
[6] Gen Univ Hosp, Prague 12800, Czech Republic
关键词
Alzheimer's disease; tauopathy; amyloid beta; membrane dysfunction; BETA-PROTEIN; APOLIPOPROTEIN-E; A-BETA; NEURODEGENERATION; PATHOGENESIS; CLEARANCE; OLIGOMERS; PLAQUES; MODEL; TAU;
D O I
10.3390/ijms25179689
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid cascade hypothesis postulates that extracellular deposits of amyloid beta (A beta) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, A beta(42) anchored at the periphery of neuritic plaques, making internalization of the LRP1-A beta(42) complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting A beta(42) production but also, perhaps paradoxically, preventing the formation of LRP1-A beta(42).
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis
    Dong, Suzhen
    Duan, Yale
    Hu, Yinghe
    Zhao, Zheng
    TRANSLATIONAL NEURODEGENERATION, 2012, 1
  • [22] Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
    Suzhen Dong
    Yale Duan
    Yinghe Hu
    Zheng Zhao
    Translational Neurodegeneration, 1 (1)
  • [23] Amyloid Protein in Alzheimer's Disease
    Xiao, Biao
    Chu, Chao-Yang
    Shan, Jiang-Hui
    Wang, Qing-Juan
    Shen, Wei
    Xie, Kai
    Li, Li-ping
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (08) : 1806 - 1825
  • [24] The new genetic landscape of Alzheimer's disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
    Dourlen, Pierre
    Kilinc, Devrim
    Malmanche, Nicolas
    Chapuis, Julien
    Lambert, Jean-Charles
    ACTA NEUROPATHOLOGICA, 2019, 138 (02) : 221 - 236
  • [26] The amyloid hypothesis of Alzheimer's disease at 25years
    Selkoe, Dennis J.
    Hardy, John
    EMBO MOLECULAR MEDICINE, 2016, 8 (06) : 595 - 608
  • [27] Amyloid-β in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019
    Daly, Timothy
    Houot, Marion
    Barberousse, Anouk
    Agid, Yves
    Epelbaum, Stephane
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) : 1309 - 1317
  • [28] The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
    McGeer, Patrick L.
    McGeer, Edith G.
    ACTA NEUROPATHOLOGICA, 2013, 126 (04) : 479 - 497
  • [29] Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?
    Tayeb, Haythum O.
    Murray, Evan D.
    Price, Bruce H.
    Tarazi, Frank I.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (07) : 1075 - 1084
  • [30] Autophagy Dysfunction in Alzheimer's Disease
    Li, Liang
    Zhang, Xiaojie
    Le, Weidong
    NEURODEGENERATIVE DISEASES, 2010, 7 (04) : 265 - 271